Evidence map›Paper›PMID 39515580›Full record

Trial reportBiological psychiatry. Cognitive neuroscience and neuroimaging2025

Comparing the Neurocognitive Effects of Right Unilateral Ultra-Brief Pulse Electroconvulsive Therapy and Magnetic Seizure Therapy for the Treatment of Major Depressive Episode.

Shawn M McClintock, Zhi-De Deng, Mustafa M Husain, Vishal J Thakkar, Elisabeth Bernhardt, Richard D Weiner, Bruce Luber, Sarah H Lisanby

Abstract readRandomized Controlled TrialMulticenter StudyComparative Study
In one paragraph

Trial report in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shawn M McClintockDepartment of Psychiatry, UT Southwestern Medical Center, Dallas, Texas; Perot Foundation Neuroscience Translational Research Center, O'Donnell Brain Institute, UT Southwestern Medical Center, Dallas, Texas. Electronic address: shawn.mcclintock@utsouthwestern.edu.
Zhi-De DengNoninvasive Neuromodulation Unit, Experimental Therapeutics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.
Mustafa M HusainDepartment of Psychiatry, UT Southwestern Medical Center, Dallas, Texas; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.
Vishal J ThakkarDepartment of Psychiatry, UT Southwestern Medical Center, Dallas, Texas.
Elisabeth BernhardtSchool of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Richard D WeinerDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.
Bruce LuberNoninvasive Neuromodulation Unit, Experimental Therapeutics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland.
Sarah H LisanbyNoninvasive Neuromodulation Unit, Experimental Therapeutics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.

Funding

Non-invasive Neuromodulation Unit (NNU)ZIAMH002955 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI ZARATE, CARLOS · 2016 to 2025
$40.3M
Duke CTSA (Composite)KL2TR001115 · NCATS · DUKE UNIVERSITY · PI BOULWARE, LEIGH E, KRAFT, MONICA · 2013 to 2017
$5.1M
Translational Research Evaluating Neurocognitive Memory Processes (TREC-MP)K23MH087739 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI MCCLINTOCK, SHAWN M · 2010 to 2014
$641k
Intramural NIH HHS Z99 MH999999Intramural NIH HHS ZIA MH002955NCATS NIH HHS KL2 TR001115NIMH NIH HHS K23 MH087739
6 · The paper itself

Abstract

backgroundMagnetic seizure therapy (MST) is under investigation as a treatment for adults with major depression. Previous research has suggested that MST has antidepressant efficacy comparable to that of electroconvulsive therapy (ECT), but with greater cognitive safety. The objective of the study was to compare the neurocognitive outcomes of patients receiving an acute course of MST with the outcomes of those receiving ECT for the treatment of major depressive episode.

methodsThis was a between-subjects, double-masked, randomized, multicenter clinical trial. Seventy-three participants with a severe major depressive episode were enrolled and randomly assigned to treatment with MST (n = 35) or ultra-brief pulse right unilateral ECT (n = 38). The main outcome was change in performance from baseline to the end of acute treatment on multiple neurocognitive measures.

resultsCompared with patients who received ECT, patients who received MST had superior cognitive outcomes up to 72 hours posttreatment. Specifically, following MST treatment, there was significant improvement in fine motor dexterity (p = .017) and no significant change in cognitive domains of attention, verbal fluency, executive function, or verbal learning and memory. In contrast, following treatment with ECT, patients demonstrated significantly worse performance on measures of verbal fluency (p < .001), executive function (p = .038), and verbal memory retention (p < .001). Autobiographical memory consistency decreased significantly following treatment with both ECT (p < .001) and MST, although the magnitude of change was greater for ECT.

conclusionsThe study findings confirm previous work and provide new evidence supporting the enhanced cognitive safety of MST relative to ECT. Future research on MST is warranted to optimize its application to individuals with neuropsychiatric illnesses across the life span.

Indexed as

CognitionElectroconvulsive TherapyMagnetic Field TherapyMajor Depressive DisorderAdultDouble-Blind MethodFemaleHumansMaleMiddle AgedNeuropsychological TestsTreatment OutcomeElectroconvulsive therapy (ECT)Magnetic seizure therapy (MST)Major depressionMemoryNeurocognitiveNeuromodulation

Identifiers

PMID39515580
PMCPMC12923074

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.